WBA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
WBA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Walgreens Boots Alliance's Free Cash Flow for the three months ended in Feb. 2024 was $-989 Mil. Walgreens Boots Alliance's Revenue for the three months ended in Feb. 2024 was $37,052 Mil. Therefore, Walgreens Boots Alliance's FCF Margin % for the quarter that ended in Feb. 2024 was -2.67%.
As of today, Walgreens Boots Alliance's current FCF Yield % is -11.30%.
The historical rank and industry rank for Walgreens Boots Alliance's FCF Margin % or its related term are showing as below:
During the past 13 years, the highest FCF Margin % of Walgreens Boots Alliance was 5.56%. The lowest was -1.22%. And the median was 3.51%.
The historical data trend for Walgreens Boots Alliance's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walgreens Boots Alliance Annual Data | |||||||||||||||||||||
Trend | Aug14 | Aug15 | Aug16 | Aug17 | Aug18 | Aug19 | Aug20 | Aug21 | Aug22 | Aug23 | |||||||||||
FCF Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
3.24 | 3.37 | 3.15 | 1.63 | 0.10 |
Walgreens Boots Alliance Quarterly Data | ||||||||||||||||||||
May19 | Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | Nov23 | Feb24 | |
FCF Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.71 | -1.54 | 1.57 | -2.14 | -2.67 |
For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Walgreens Boots Alliance's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Walgreens Boots Alliance's FCF Margin for the fiscal year that ended in Aug. 2023 is calculated as
FCF Margin | = | Free Cash Flow (A: Aug. 2023 ) | / | Revenue (A: Aug. 2023 ) |
= | 141 | / | 139081 | |
= | 0.10 % |
Walgreens Boots Alliance's FCF Margin for the quarter that ended in Feb. 2024 is calculated as
FCF Margin | = | Free Cash Flow (Q: Feb. 2024 ) | / | Revenue (Q: Feb. 2024 ) |
= | -989 | / | 37052 | |
= | -2.67 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Walgreens Boots Alliance's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nancy M Schlichting | director | 200 WILMOT ROAD, DEERFIELD IL 60015 |
Timothy C Wentworth | director, officer: Chief Executive Officer | C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121 |
Richard P. Gates | officer: SVP, Chief Pharmacy Officer | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Neal J. Sample | officer: EVP, Chief Information Officer | 200 VESEY STREET, NEW YORK NY 10285 |
Todd Heckman | officer: Interim Global Controller | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Polen Thomas E Jr | director | BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
John Patrick Driscoll | officer: EVP, Pres. U.S. Healthcare | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Rosalind G Brewer | director, officer: CEO | C/O MOLSON COORS BREWING COMPANY, 1225 17TH STREET, SUITE 3200, DENVER CO 80202 |
Kevin M. Ban | officer: EVP, Chief Medical Officer | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Bryan C Hanson | director | ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580 |
Henry Lee Cooper | officer: EVP, Pres. Walgreens Pharmacy | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Tracey D Brown | officer: SVP, Pres., Walgreens Retail | 675 AVENUE OF THE AMERICAS, 6TH FLOOR, NEW YORK NY 10010 |
Inderpal S Bhandari | director | C/O WALGREENS BOOTS ALLIANCE, INC., DEERFIELD IL 60015 |
Steven J Shulman | director | 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329 |
Holly May | officer: EVP, Global Chief HR Officer | 6301 FITCH PATH, NEW ALBANY OH 43054 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.